There are 2137 resources available
1194P - Identification and validation of circulating tumour DNA methylation markers for lung nodule stratification
Presenter: Zhoufeng Wang
Session: E-Poster Display
Resources:
Abstract
1195P - The value of detecting resistance through liquid biopsy
Presenter: Scott Laurie
Session: E-Poster Display
Resources:
Abstract
1196P - Identification of targetable alterations using NGS-based liquid biopsy in NSCLC patients
Presenter: Andrea Moreno-Manuel
Session: E-Poster Display
Resources:
Abstract
1197P - Changes in the concentration of EGFR-mutated (EGFR-M+) plasma DNA in the first hours of TKI therapy allow the prediction of tumour response in patients with EGFR-M+ NSCLC
Presenter: Ekaterina Kuligina
Session: E-Poster Display
Resources:
Abstract
1198P - Digital droplet PCR-based detection of TP53 mutations in circulating DNA for the disease monitoring in patients with hereditary ovarian or breast cancer
Presenter: Evgeny Imyanitov
Session: E-Poster Display
Resources:
Abstract
1199P - Identification of patient specific immune therapy treatment sensitivity by ex vivo testing
Presenter: Fanny Grillet
Session: E-Poster Display
Resources:
Abstract
1200P - Tyrosine kinase activity profiling as a predictive biomarker for clinical benefit to immune checkpoint inhibition in advanced melanoma and NSCLC
Presenter: Karlijn Joode
Session: E-Poster Display
Resources:
Abstract
1201P - The role of a mini tumour mutational burden (TMB) score generated with a customized NGS panel to predict benefit from immunotherapy
Presenter: Pasquale Lombardi
Session: E-Poster Display
Resources:
Abstract
1202P - Identification of a gene signature closely related to immunosuppressive tumour microenvironment predicting prognosis of patients in EGFR mutant lung adenocarcinoma
Presenter: Jia Li
Session: E-Poster Display
Resources:
Abstract
1203P - Prognostic implication of clinical decision support system (CDSS) for colorectal cancer
Presenter: In Hee Lee
Session: E-Poster Display
Resources:
Abstract